Quantitative Insights (QI) was founded in 2010, and is based on technology that was created in the laboratory of Dr. Maryellen Giger, Ph.D., from the University of Chicago. Quantitative Insights is dedicated to improving patient management by harnessing the power of cutting-edge research and advanced imaging solutions to create an intuitive computer-aided diagnosis (CADx) workstation.
QI’s team includes technology leaders, innovators, and entrepreneurs, who have a history of successful fundraising, company formation, and successful exit. QI’s management team and advisors have been responsible for many of the transformative changes in the CAD industry over the past few decades. They have taken CAD products to market, have led definitive clinical trials in the imaging industry and have worked to help redefine CAD standards.
QI’s first product has been submitted for FDA review and the company is now positioned to launch its flagship product in the US and select global markets. We are actively recruiting the industry’s influencers to work with us in our Early Adopter Program (EAP) to redefine the way MR imaging is utilized in the diagnosis and treatment of breast cancer. For more information on the EAP, please use the link below to contact us.